SANUWAVE Health (SANUWAVE Health) GF Value : $0.07 (As of Apr. 27, 2024)

View and export this data going back to 2008. Start your Free Trial

What is SANUWAVE Health GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-27), SANUWAVE Health's share price is $0.0205. SANUWAVE Health's GF Value is $0.07. Therefore, SANUWAVE Health's Price-to-GF-Value for today is 0.29.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes SANUWAVE Health is Possible Value Trap, Think Twice.

SANUWAVE Health (OTCPK:SNWV) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

SANUWAVE Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0205	/	0.07
	=	0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SANUWAVE Health GF Value Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SANUWAVE Health (SANUWAVE Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

11495 Valley View Road, Eden Prairie, MN, USA, 30024

Website

https://www.sanuwave.com

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Executives

Andrew Walko	officer: President	11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
James E Besser	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p.	director, other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank	director	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price	director	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh	officer: President	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii	10 percent owner	200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski	director	99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc.	director	3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom	officer: Interim CFO	11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli	director, officer: Chief Executive Officer	510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins	officer: Chief Financial Officer	11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino	director	PO BOX 376, LOBBY L., ANN ARBOR MI 48105